device · product 1 of 1
COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.
- Recall number
- Z-0401-2021
- Initiated
- September 30, 2020
- Classification
- Class II
- Status
- Ongoing
- Recalling firm
- Merz North America, Inc.
- Quantity
- 2051 units
App-derived interpretation
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Official device-enrichment evidence · Sourced
Labeling design
Inspect official wording and provenance
Reason for recall
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Code information
Model M0068903000, Lots: 100127846, 100127847, 100128709, 100128710, 100129357, 100129614, and 100129615
Distribution pattern
US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV